CRISPR-Cas9 editing could one day be used to treat familial haemophagocytic lymphohistiocytosis (FHL), scientists have reported.
The technique has been used successfully in a mouse model of the disease. Laboratory analysis of cells from human pati...
6 months ago
The genetic causes of side-effects to direct oral anticoagulants are to be the subject of an investigation in the UK as part of a pioneering project.
Known as the Yellow Card Biobank, the project involves the Medicines and Healthcare products Regu...
6 months ago
